Refiners Continue T...
Health Care: Health Services
Enzo Biochem Inc. (ENZ: NYSE)
$2.24 -0.01 | -0.44%
05/23/13 - 04:04 PM ET
42.83K / 103.10K
Vol / Avg. Vol:2.23 / 2.25
Open / Prev. Close:2.22 - 2.27
Today's Range:1.33 - 3.16
52 Wk Range:-16.67%
Performance YTD:TheStreet Rating:
Portfolios with ENZ
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- UserBarron's Insider Purchases ...
- ContributorStockerblog.com Gene Therap...
- Userkelvinenz Portfolio 1
- UserS-0022
- UserTraderSteveUK Portfolio 1
- UserRT_in_CA
- UserSo far, I'm beating the S&a...
Latest ENZ Headlines from TheStreet
- Interesting ENZ Call For January 2014 05.20.13 | 12:05 pm
- 4 Big Volume Gainers Under $10 11.13.12 | 06:11 pm
- 5 Stocks Poised for Breakouts 09.21.12 | 12:09 pm
- Thursday Earnings Live Blog 10.14.10 | 04:10 pm
- Investors May See Upside Down Under 09.16.10 | 08:09 am
- Enzo Biochem 1Q Loss Narrows On Revenue Boost 12.10.09 | 04:12 pm
- Enzo Biochem 4Q Loss Widens On Costs 10.14.09 | 06:10 pm
- Tuesday's Health Winners & Losers 10.16.07 | 04:10 pm
- Enzo Biochem Falls on Court Dismissal 09.07.07 | 02:09 pm
- Friday's Health Winners & Losers 09.07.07 | 02:09 pm
Press Releases for ENZ
- Enzo Biochem Reports Fiscal Second Quarter Results - Business Wire 03.12.13 | 04:03 pm
- Enzo Biochem Schedules Teleconference To Discuss Second Quarter Results On March 13, 2013 At 8:30 AM E.T. - Business Wire 03.08.13 | 01:03 pm
- Enzo Biochem Reports First Quarter Results - Business Wire 12.10.12 | 04:12 pm
- Enzo Biochem Schedules Teleconference To Discuss First Quarter Results On December 11, 2012 At 8:30 AM E.T. - Business Wire 12.06.12 | 11:12 am
- Enzo Biochem To Present At Canaccord Genuity 2012 Medical Technology & Diagnostics Forum - Business Wire 11.29.12 | 03:11 pm
- Enzo Biochem’s Clinical Labs Introduces Diagnostic Test That Assists In Early Detection Of Lung Cancer - Business Wire 11.13.12 | 07:11 am
- Enzo Biochem To Present At Lazard Capital Markets 9th Annual Healthcare Conference - Business Wire 11.12.12 | 11:11 am
- Enzo Biochem Reports Jury Declares Life Technologies Infringed Company Patents And Awards Enzo $48.6 Million - Business Wire 11.02.12 | 09:11 am
- Enzo Biochem Reports Fourth Quarter Results And Announces Realignment Program Expected To Reduce Annualized Costs $6 Million Commencing With Fiscal First Quarter - Business Wire 10.15.12 | 04:10 pm
- Enzo Biochem Schedules Teleconference To Discuss Fourth Quarter Results On October 16, 2012 At 8:30 AM E.T. - Business Wire 10.12.12 | 03:10 pm
Partner Headlines for ENZ
- Pre-Market Earnings Report for December 11, 2012 : DG, PTRY, ENZ, HSOL - NASDAQ 12.10.12 | 09:12 pm
- Investors Should Wait Out Quest & LabCorp - Seeking Alpha 02.16.12 | 09:02 am
- Enzo Biochem: Personalized Medicine Is More Than Targeted Therapeutics - Seeking Alpha 04.03.11 | 07:04 am
- Competitive Technologies: Short Squeeze Coming or Another Leg Down? - Seeking Alpha 08.25.10 | 09:08 am
- Top 5 Percentage Gainers On NYSE (DV, CKH, ENZ, LAD, CMG) - Benzinga 07.23.10 | 03:07 pm
- MB FINANCL INC (MBFI) - Profit Tracks - Zacks 04.13.10 | 01:04 am
- UPDATE 2-Enzo wins round in Applera patent fight - Reuters 03.26.10 | 04:03 pm
